Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients
Ontology highlight
ABSTRACT: Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients
PROVIDER: PRJNA595388 | ENA |
REPOSITORIES: ENA
ACCESS DATA